SUNDARAM FINANCE LTD
SUNDARMFIN.NS NSEThere isn't enough cash-flow history to value Sundaram Finance Ltd yet. Its growth outlook scores strong; the balance sheet looks stretched.
At a glance
tap a tile to dig inOtto's verdict
the tiles above, in a line each- Health 9 of 16 health checks pass.
- Growth Revenue trend ≈ +15%/yr (extended trend, not a forecast).
- Street Analysts lean buy · avg target +13% from here.
- Dividend Pays a dividend — yields 0.88%.
Not investment advice — Otto just crunches numbers.
Price trend
-10.8% over one year · NIFTY 50 -3.2%
What think
The market's move: -10.8% over the past year
Trading 33% up its 52-week range. Price is the market's live vote — not advice.
Analyst consensus: Buy · 9 analysts
Average 12-month target $53.36 — +12.6% vs today.
Yahoo Finance's analyst aggregate. Sentiment, not advice.
Insider filings come from SEC EDGAR — US companies only, so there's none for SUNDARMFIN.NS.
InvestRight readers: 0 watching
This site's own activity — not a broad measure. Sentiment, not advice.
The snowflake
checks passed on each axis- Value 0/— checks
- Future 4/4 checks
- Past 2/3 checks
- Health 0/3 checks
- Dividend 3/6 checks
What does this show?
Five quick health scores — Value, Future, Past, Health and Dividend — each 0–100%. A bigger, more even shape means a stock that scores well across the board; a spiky one is strong on some axes and weak on others.
Learn more on Investopedia →Fair value
our estimate · not analyst forecastNot enough cash-flow history to estimate a fair value for SUNDARMFIN.NS yet.
What does this show?
Our estimate of what one share is worth based on the cash the business is expected to generate (a discounted-cash-flow model), next to today's price. Below fair value hints undervalued, above hints expensive — it's an estimate, not a guarantee.
Learn more on Investopedia →Health checks
16 checks run on free data- ⚠ Debt/equity falling over time long-term debt/equity 409.0% vs 362.8%
- ⚠ Debt is under 40% of equity debt/equity 409%
- ⚠ Debt well covered by cash flow operating cash flow covers -10.0% of debt
- ⚠ Dividend covered by earnings and cash flow not fully covered
- ⚠ Growth accelerating vs its average latest 9.5%/yr vs 15.7% average
- ⚠ Yield beats the market yield 0.88% vs market ~1.5%
Show all 16 checks by axis
Value 0/— passed
- – Trading below our fair-value estimate
- – P/B below industry industry P/B not on the free feed
- – P/E below industry industry P/E not on the free feed
- – P/E below peer average peer P/Es land after the next refresh
- – P/S sane vs its own history needs multi-year P/S (Tier B)
- – More than 20% below fair value
Future 4/4 passed
- ✓ Earnings trending up 15.7%/yr over 3yr
- – Growth beats the industry industry growth not on the free feed
- ✓ Earnings growth beats the market 15.7%/yr vs market ~9.0%
- ✓ Revenue trending up 18.6%/yr over 3yr
- ✓ Return on equity improving ROE 13.8% vs 13.4% 3yr ago
Past 2/3 passed
- ✓ Earnings grew over the period 13.3B → 20.6B
- – High-quality earnings (few one-offs) one-off detection deferred — needs statement detail
- ⚠ Growth accelerating vs its average latest 9.5%/yr vs 15.7% average
- ✓ Revenue higher than five years ago 29.5B → 49.2B
- – Return on equity above 20%
Health 0/3 passed
- ⚠ Debt/equity falling over time long-term debt/equity 409.0% vs 362.8%
- ⚠ Debt is under 40% of equity debt/equity 409%
- ⚠ Debt well covered by cash flow operating cash flow covers -10.0% of debt
- – Interest comfortably covered by profit
- – Short-term assets cover long-term debt n/a
- – Short-term assets cover short-term bills n/a
Dividend 3/6 passed
- ⚠ Dividend covered by earnings and cash flow not fully covered
- ✓ Dividend growing over time over 4yr on record
- ✓ No dividend cut in recent years steady over 4yr on record
- ✓ Payout ratio under 75% payout 30.3% of earnings
- ⚠ Yield beats the market yield 0.88% vs market ~1.5%
- ⚠ Yield in the top quartile of payers yield 0.88% vs 2.36% cut among the 93 payers Otto tracks
What does this show?
Pass/fail rules on the company's finances — debt levels, profitability, cash cover and so on. More greens means a sturdier balance sheet; an n/a just means we didn't have that data point.
Learn more on Investopedia →Past performance
recent history from Yahoo FinanceRevenue
Earnings
Free cash flow
dashed line = what it'd look like growing at our ~9% market-average benchmark, for comparison
Deeper 10-yr statements are US-only for now — Otto's showing SUNDARMFIN.NS's Yahoo figures instead.
What does this show?
How revenue, earnings and free cash flow have grown over the years. Bars rising left-to-right show a growing business; the dashed line is a market-average pace for comparison.
Learn more on Investopedia →Future
trend, not analyst forecastRevenue · extended at 15.0%/yr
Earnings · extended at 15.0%/yr
Dashed bars just extend the historical trend (capped at ±15%/yr) — the same growth our DCF uses. It's arithmetic on the past, not an analyst forecast; real futures bend.
What does this show?
Solid bars are history; dashed bars simply extend the past growth trend a few years forward — capped so it stays sane. It's a trend line, not an analyst forecast.
Learn more on Investopedia →Dividend
from cash actually paid, not promisesTotal dividends paid · split-proof, unlike per-share history
What does this show?
The share of profit paid back to shareholders as cash. Yield is that cash as a % of the price; the payout gauge shows how much of earnings is paid out (over ~75% can be hard to sustain).
Learn more on Investopedia →Ownership & insiders
Insider-trade filings come from SEC EDGAR, which covers US companies only — there's no free equivalent for Indian filings yet, so Otto skips this one for SUNDARMFIN.NS.
What does this show?
Buys and sells by the company's own directors and officers, from their SEC filings. Insiders sell for many reasons, but clusters of open-market buying can signal confidence.
Learn more on Investopedia →Spot a missing competitor? Sign in to add it — it'll show for everyone.
What does this show?
A few peers in the same business, each with its own mini snowflake, so you can see how this company stacks up rather than judging it in isolation. Anyone signed in can add a missing competitor — it shows for everyone, marked as user-added.
Learn more on Investopedia →Leadership
Yahoo Finance · photos & bios via Wikidata-
Mr. Rajiv Chellappa Lochan
MD & Whole Time Director
- Age
- 54
- Total yearly comp
- $685,002
Ranked by title — reporting lines aren't public data. Compensation is the total Yahoo reports; blank means it isn't disclosed there.
In the news
No recent headlines saved — Otto grabs them on each refresh.
My notes
Sign in to keep a private decision journal on this stock — only you can see your notes.
Hi! I can explain SUNDARAM's numbers — valuation, health, the dividend, the fair-value gap. What would you like to know?
Otto explains what's on this page — not investment advice.